Zacks Research Has Weak Forecast for Haemonetics Q3 Earnings
Haemonetics Co. (NYSE:HAE – Free Report) – Investment analysts at Zacks Research dropped their Q3 2026 EPS estimates for shares of Haemonetics in a report released on Wednesday, May 28th. Zacks Research analyst R. Department now forecasts that the medical instruments supplier will post earnings of $1.33 per share for the quarter, down from their […]
